Entrust Funds Management Ltd increased its interest in ProgenPharmaceuticals Ltd on January 27 from 3.1 million (5.1pc) to 3.7 million shares (6.1pc).
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025